Securities fraud litigation history and active cases
Active Cases
0
Pending Settlement
1
Closed
0
Total Settlement
$9.75M
BioXcel Therapeutics, Inc. (BTAI) Class Action Lawsuit (July 2023)Pending Settlement
3:23cv915 • July 7, 2023
Class Period Start
March 8, 2023
Class Period End
June 28, 2023
PSLRA Deadline
September 5, 2023
Case Allegations
10b5
Statutes of Repose
Mar 8, 2026
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
June 30, 2026
Settlement Fund
$9,750,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased between March 9, 2023 and June 28, 2023, both dates inclusive.
Claim Administrator
Strategic Claims Services
600 N. Jackson St., Suite 205
Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://bioxcelsecuritiessettlement.com/Hearing Date
September 2, 2026
Opt-out Deadline
August 5, 2026
Settlement Note
Download hereProof Of Claim
Download here
Docket History
Jul 29, 2026
Motion for Final Approval of Settlement
Mar 2, 2026
Preliminary Approval of Settlement
Mar 2, 2026
Notice of Pendency
Mar 2, 2026
Proof of Claim Form
Feb 27, 2026
Motion for Preliminary Approval of Settlement
Sep 29, 2025
Third Amended Complaint
Sep 29, 2025
Motion to Dismiss Denied
Sep 6, 2024
Motion to Dismiss
Aug 1, 2024
Second Amended Complaint
Feb 6, 2024
Motion to Dismiss
Dec 5, 2023
First Amended Complaint
Oct 4, 2023
Appointment of Lead Plaintiff
Jul 7, 2023
First Filed Complaint
TOP
